Preclinical Explorative Assessment of Celecoxib-Based Biocompatible Lipidic Nanocarriers for the Management of CFA-Induced Rheumatoid Arthritis in Wistar Rats

AAPS PharmSciTech
Pradip NirbhavaneOm Prakash Katare

Abstract

Celecoxib (CXB), a COX-2 inhibitor, is primarily indicated for long-term treatment of rheumatoid arthritis (RA). The effective therapeutic efficacy of CXB on RA via oral administration shows adverse systemic complications, and therefore, local application of CXB has been recommended. The aim of the present study was to develop and characterize solid lipid nanoparticles (SLNs) with enhanced skin permeation potential of CXB. The particle size, polydispersity index (PDI), and percentage drug entrapment (PDE) of the developed SLNs (CXB-SLNs) were found to be 240 nm, < 0.3, and ~ 86% respectively. The developed SLNs exhibited sustained release up to 70% at the end of 48 h. Drug permeation was found to be 45% for SLN gel and 31% for conventional gel. The dermatokinetic studies also confirmed enhanced permeation of CXB in the epidermis and dermis and revealed superiority of the developed SLN gel vis-à-vis the conventional gel. Further, in the CFA-induced arthritis rat model, % arthritis index (AI) of the CXB-SLN gel formulation was found to be very less (18.54%) as compared to untreated (187.34%) and conventional gel-treated (91.61%) animals. In conclusion, the current study can provide a suitable alternative for the development of an...Continue Reading

References

Mar 4, 2000·International Journal of Pharmaceutics·C S MaiaM Schäfer-Korting
Sep 25, 2001·Lancet·D M Lee, M E Weinblatt
Mar 5, 2003·International Journal of Pharmaceutics·Sylvia A Wissing, Rainer H Müller
Jul 3, 2003·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Sylvia A Wissing, Rainer H Müller
Apr 15, 2004·International Journal of Pharmaceutics·A K Kohli, H O Alpar
May 11, 2006·Skin Pharmacology and Physiology·H Trommer, R H H Neubert
Jun 5, 2007·Advanced Drug Delivery Reviews·Monika Schäfer-KortingHans-Christian Korting
Jul 27, 2007·International Journal of Pharmaceutics·Medha Joshi, Vandana Patravale
Sep 20, 2007·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Sanjula BabootaSheikh Shafiq
Sep 22, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vaibhav DubeyN K Jain
May 24, 2008·International Journal of Cosmetic Science·S A Wissing, R H Müller
Jul 7, 2009·Expert Opinion on Therapeutic Patents·Ling-Dong QuanDong Wang
Oct 14, 2010·BMC Complementary and Alternative Medicine·Sanmugapriya EkambaramVenkataraman Subramanian
Dec 14, 2011·The New England Journal of Medicine·Iain B McInnes, Georg Schett
Jan 24, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Michal BacharDganit Danino
Jan 30, 2013·Colloids and Surfaces. B, Biointerfaces·Kaisar RazaOm Prakash Katare
Jul 14, 2014·Colloids and Surfaces. B, Biointerfaces·Amit K JainGovind P Agrawal
Jun 29, 2016·AAPS PharmSciTech·Pradip NirbhavaneGopal Krishan Khuller
Jun 10, 2017·The Cochrane Database of Systematic Reviews·Sarah E GarnerGeorge A Wells
Sep 12, 2017·Current Drug Metabolism·Michael W Sinz
Oct 27, 2017·Advances in Therapy·Teresa A SimonJohn M Esdaile

❮ Previous
Next ❯

Citations

Mar 16, 2019·Expert Opinion on Drug Delivery·Riya BangiaOm Prakash Katare
Mar 25, 2019·AAPS PharmSciTech·Manoj Kumar GautamRenu Chadha
Jul 23, 2020·Advanced Drug Delivery Reviews·Romain BrusiniPatrick Couvreur
Oct 1, 2021·International Journal of Pharmaceutics·Parastou RahimizadehSung In Lim

❮ Previous
Next ❯

Software Mentioned

TIA
GraphPad Prism
Rheoplus

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.